Division of Endocrinology & Diabetes

Achievements and Awards

  • Thyroid physiology and disease research from four epochs dating from 1920 to the present have benefited the thyroid health of millions of people. Dr. Martin I. Surks has recently summarized the major contributions
  • Yousin Suh's team was awarded part of a $11.2 million grant from the NIH to study the impact of damge to DNA on aging and disease. Specifically, Dr. Suh will use tissue samples from Ashkenazi Jewish centenarians to look for longevity-associated gene variations and insert them into otherwise ordinary human cells to observe whether the inserted genes improve cellular function.  
  • Michael Brownlee co-authored a study finding that an iron-removing drug reduces the time it takes diabetic wounds to heal in mice.  
  • Michael Brownlee received the Juvenile Diabetes Research Foundation's David Rumbough Award for Scientific Excellence. read more 
  • Jesse Roth was recently interviewed by The New York Times on the downside of body fat's highly activated defense system. read more... 
  • Nir Barzilai co-authored a study finding that a cellular protein that may prevent nerve cells from dying also helps to improve insulin action and lower blood glucose levels.  
  • Rita Louard was quoted in an Ebony magazine article on diabetes. read more 
  • Nir Barzilai and Yousin Suh authored a study finding that mutations in genes governing an important cell-signaling pathway influence human longevity.  
  • Clemence Blouet, PhD (Endocrinology) received one of two Belfer Prizes for Outstanding Postdoctoral Research. read more 
  • Over the past 30 years, 4 current or former members of the Division have been awarded the Outstanding Scientific Accomplishment Award (Lilly Award) of the American Diabetes Association and 2 have won the Banting Award of the American Diabetes Association.  Dr. Michael Brownlee has won both and the Claude Bernard Award of the European Association for the Study of Diabetes. 
  • Ora Rosen MD, now deceased, played a significant role in the cloning of the insulin receptor.
  • Drs. Jack Oppenheimer, while at Montefiore and Einstein,  and Martin Surks made major contributions to our understanding of thyroid hormone production and metabolism and to the mechanism of thyroid hormone action. 
  • Howard Eder discovered that type two diabetics have low HDL cholesterol levels. 
  • Robert Bookchin and Helen Ranney (Einstein hematologists) discovered that HbA1c was elevated in diabetics.
  • Michael Brownlee, MD  developed a unifying mechanism that explains the etiology of the diverse microvascular complications of diabetes and offers potential preventive avenues for therapy.  For his research work, he is the recipient of the Outsanding Scientific Achievement Award and the Banting Medal of the American Diabetes Association, and the Claude Bernard Award of the European Association for the Study of Diabetes.
  • Norman Fleischer, in collaboration with Dr. Shimon Efrat, now at Tel Aviv University, developed a series of murine beta cell lines with regulatable growth and insulin production and secretion.
  • Luciano Rossett, MD, now an executive witrh Merck, Inc., in a series of high profile papers discovered  the role of the hypothalamus in the regulation of glucose production by the liver.
  • Nir Barzilai, MD has discovered that several genes related to metabolism are linked to human longevity
  • Maureen Charron (primary in biochemistry) cloned the insulin responsice glucose transporter (GLUT4), and Jeff Pessin has substantively determined the effect of insulin on its function
  • Harry Shamoon along with Jill Crandall have led Einstein’s participation in  major clinical trials, including  Diabetes Control and Complications Trial (DCCT), which established that "tight control" of glycemia mitigated the development of microvascular and neuropathic complications in Type 1 Diabetes, and the Diabetes Prevention Program that demonstrated that type 2 diabetes onset can be substantially delayed by diet and exercise and certain drugs.
Click here to log in